Case report
Open access
Aug 2026
Response to Galcanezumab in a Patient with Complex Neuropsychiatric Comorbidity: A Case Report
This case illustrates that complex neuropsychiatric comorbidity and psychotropic polypharmacotherapy did not preclude an apparent clinical benefit from galcanezumab, and highlights the potential value of coordinated neurological and psychiatric monitoring in patients with migraine and complex neuropsychiatric profiles.
Anna Anselmo, Maria Pagano, F. Corallo et al.
· Journal of Clinical Medicine · 0 citations